Skip to main content
Contact Info
Dr. Harikrishna Reddy
8725984535
Department of Pharmacology, Lab No 402, Academic Block, Ghudda Bathinda-151401
Dr. Harikrishna Reddy
Qualification

M.Pharm, Ph.D.,FSASS

Education

Experience
Teaching Experience 3 Years

Assistant Professor, Department of Pharmacology, Central University of Punjab, Bathinda (January 2020- Till date).

Research Experience 8 Years

Administrative Experience:

Convener, Academic and Administrative Committee, Department of Pharmacology

Member, Curriculum Design and Development Committee, Department of Pharmacology

Research Area

Neuropharmacology

Research Interests
  • Pharmacology
  • Neuroscience
  • Stem Cells
  • Pharmacovigilance
Research Grants/Projects
  • "Stem cell proteins as a novel therapeutics in repairing brain damage triggered by cerebral stroke" Research seed money grant funded by Central University of Punjab.
  • "Stem cell derived secretome for the treatment of Alzheimer’s disease: A novel approach"-UGC-BSR Research Startup Grant by UGC

 

Professional Affiliation
  • Life time member of Association of Basic Medical Scientists (ABMS)
  • Life time member of International Society for Research and Development
  • Member of International Organization of Scientific Research and Development
  • Member of American Neurological Association
Professional Recognition/Awards/Scholarships
  1. Best Student Award of batch in graduation
  2. Outstanding Grade in M. Pharmacy
  3. PGIMER-Merit Scholarship
  4. ICMR Young Scientist International Travel Award to Canada
  5. Human Brain Project Travel grant to Manchester, UK
  6. Chhuttani Charitable Trust Cash Prize to attend International conference
  7. Research Training Group Fellowship to Germany
  8. Graduate Pharmacy Aptitude Test -GPAT
  9. Indian Council of Medical Research- ICMR-JRF
  10. CUPB- Research Award- 2023
  11. CUPB- Research Award- 2024
Research Collaboration

Post Graduate Institute of Medical Education and Research, Chandigarh

AIIMS-Guwahati

Publications
Articles-26
Books-01
Book Chapters-04

Recent Publications:

S Kumari, R Dhapola, P Sharma, S K. Singh, D HariKrishna Reddy* , Implicative role of cytokines in neuroinflammation mediated AD and associated signaling pathways: Current progress in molecular signaling and therapeutics, Ageing Res. Rev. (2023). https://doi.org/10.1016/j.arr.2023.102098. (Impact Factor-13.1)

S.K. Beura, R. Dhapola, A.R. Panigrahi, P. Yadav, R. Kumar, D.H. Reddy*, S.K. Singh, Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases, Med. Res. Rev. (2023). https://doi.org/10.1002/MED.21965. (Impact Factor-13.3)

S. Kumari, R. Dhapola, D.H.K. Reddy*, Apoptosis in Alzheimer’s disease: insight into the signaling pathways and therapeutic avenues, Apoptosis. (2023) 1–15. https://doi.org/10.1007/S10495-023-01848-Y/FIGURES/3. (Impact Factor-7.2)

P. Nagar, P. Sharma, R. Dhapola, S. Kumari, B. Medhi, D. HariKrishnaReddy*, Endoplasmic reticulum stress in Alzheimer’s disease: Molecular mechanisms and therapeutic prospects, Life Sci. (2023) 121983. https://doi.org/10.1016/J.LFS.2023.121983. (Impact Factor-6.1)

S.K. Beura, R. Dhapola, A.R. Panigrahi, P. Yadav, D.H. Reddy*, S.K. Singh, Redefining oxidative stress in Alzheimer’s disease: Targeting platelet reactive oxygen species for novel therapeutic options, Life Sci. 306 (2022) 120855. https://doi.org/10.1016/J.LFS.2022.120855. (Impact Factor-6.1)

R. Dhapola, · Subhendu, S. Hota, P. Sarma, · Anusuya Bhattacharyya, B. Medhi, · Dibbanti, H. Reddy*, Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease, Inflammopharmacology. 29 (2021) 1669–1681. https://doi.org/10.1007/S10787-021-00889-6. (Impact Factor-5.8)

R. Dhapola, P. Sarma, B. Medhi, A. Prakash, D.H. Reddy*, Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer’s Disease, Mol. Neurobiol. (2021) 1–21. (Impact Factor-5.1)

S. Thakur, R. Dhapola, P. Sarma, B. Medhi, D.H.K. Reddy*, Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics, Inflammation. (2022) 1–17. https://doi.org/10.1007/S10753-022-01721-1/TABLES/1. (Impact Factor-5.1)

J.S. Bhatti, S. Kaur, J. Mishra, H. Dibbanti, A. Singh, A.P. Reddy, G.K. Bhatti, P.H. Reddy, Targeting dynamin-related protein-1 as a potential therapeutic approach for  mitochondrial dysfunction in Alzheimer’s disease., Biochim. Biophys. Acta. Mol. Basis Dis. 1869 (2023) 166798. https://doi.org/10.1016/j.bbadis.2023.166798. (Impact Factor-6.6)

 

Research Guidance

Ph.D Students

  • Rishika Dhapola -INSPIRE Fellow
  • Prajjwal Sharma
  • Sneha Kumari

M.Pharm Students (2019-2021)

  • Rishika Dhapola (Gold Medalist)
  • Subhendu Shekhar Hota

M.Pharm Students (2020-2022)

  • Prajjwal Sharma
  • Sujata Thakur
  • Saurabh Gautam

M.Pharm Students (2021-2023)

  • Sneha Kumari
  • Pushank Nagar

M.Pharm Students (2021-2023)

  • Mohit Paidlewar
  • Vanshu Bhardwaj
  • Rutweek Kulkarni
Conference/ Workshops/Seminars Attended
National:  >30
International:  4
Conference/ Workshops/Seminars Organised
National Level: 4
International Level: 1

 

Peer Recognition

Editor:

J Behav Neurosci

 EC Neurology

Biochemistry and Biotechnology Research

Invited Talks/ Resource Person
1. 4th Advanced Training Program in Behavioral Neurosciences - (Nov-Dec, 2019)
2. 1st Advanced Training Program in Behavioral Neurosciences - (August 22-27, 2016)
3. 2nd National Symposium cum workshop on Experimental Research and Alternatives (NSWERA)- (17th November 2017)
4. Annual Meetings of SNCI, conducted by University of Hyderabad, Hyderabad- (Dec, 2020)
5. 6th Advanced Training Program in Experimental Behavioral Neurosciences – (19th – 21st January 2023)
6. 7th Advanced Training Program in Experimental Behavioral Neurosciences – (15th – 17th February 2024)

Patent Filed/ Published
PATENT FILED
PATENT PUBLISHED